BROWSE·page 507 of 1515

Browse EX-10 agreements

18,173 total material contract exhibits.


EX-10.1

Core Scientific, Inc./tx

339441540 v11 Execution Version CREDIT AGREEMENT dated as of August 25, 2026, among CORE SCIENTIFIC, INC., as the Borrower, THE LENDERS AND ISSUING BANKS PARTY HERETO, JPMORGAN CHASE BANK, N.A., as Administrative Agent and Collateral Agent, MORGAN STANLEY SENIOR FUNDING, INC., JPMORGAN CHASE BANK, N.A., GOLDMAN SACHS LENDING PARTNERS LLC, AND TD SECURITIES (USA) LLC, as Joint Bookrunners


339441540 v11 -i- TABLE OF CONTENTS Page ARTICLE I DEFINITIONS ........................................................................................................................................ 1 Section 1.01 Defined Terms .................................................................................................................. 1 Section 1.02 Terms Generally; GAAP ................................................................................................ 42 Section 1.03 Letter of Credit Amounts ................................................................................................ 43 Section 1.04 Timing of Payment or Performa

…

EX-10.1·8-K·CIK 1839341·ACC 0001839341-26-000021·Filed Aug 27, 2026, 07:07 ET

EXHIBIT 10.1

BUILD-A-BEAR WORKSHOP INC

SEPARATION AND RELEASE AGREEMENT

This Separation and Release Agreement (the “Agreement”) is made between Build-A-Bear Workshop, Inc., a Delaware corporation (the “Company”), and David Henderson (“Employee”) (each a “party” and together the “parties”):

WHEREAS, the Company entered into that certain Amended and Restated Employment, Confidentiality and Noncompete Agreement, which became effective as of June 11, 2026 (the “Employment Agreement”), with Employee, pursuant to which Employee currently serves as Chief Growth Officer of the Company.

WHEREAS, the Company now desires, pursuant to Section 4.1(c) thereof, to terminate the Employment Agreement and the Employee’s employment with the Company, without Cause (as defined therein), effective as of August 26, 2026 (the “Separation Date”).

WHEREAS, the parties wish to ensure an amicable separation and to provide for the release in full of all claims by Employee.

NOW, THEREFORE, the parties agree as follows:

…

EX-10.1·8-K·CIK 1113809·ACC 0001437749-26-029054·Filed Aug 27, 2026, 06:55 ET

EX-10.1

JUPITER NEUROSCIENCES, INC.

** **

Form of Debt Forgiveness and Release Agreement

** **

Dated as of August 26, 2026

This Debt Forgiveness and Release Agreement (this “Agreement”), dated as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware corporation (the “Company”) and ____________ (“Counterparty”). Each of the Company and Counterparty may be referred to herein individually as a “Party” and collectively as the “Parties”.

RECITALS

WHEREAS, Counterparty is engaged by the Company as an employee, officer, consultant or in another position, and the Company currently owes the Counterparty the sum of $________ (the “Cash Debt”);

WHEREAS, Counterparty now desires to terminate and forgive The Cash Debt $_________ (the “Debt”), and provide the release and other agreements as set forth herein;

…

EX-10.1·8-K·CIK 1679628·ACC 0001493152-26-040308·Filed Aug 27, 2026, 06:30 ET

AM PM Group Limited

**Ritter House, Wickhams Cay II, PO Box 3170, Road Town, Tortola VG1110, British Virgin Islands

**

Date: July 6, 2026

Re: Director Offer Letter for Sun Wai Kenneth Liu

** **

Dear Sun Wai Kenneth Liu:

AM PM Group Limited, a British Virgin Islands company with limited liability (the “Company” or “we”), is pleased to offer you a position as an Independent Director of the Company. We believe your background and experience will be a significant asset to the Company and we look forward to your participation as an Independent Director in the Company. Should you choose to accept this position as an Independent Director, this offer letter shall constitute an employment agreement between you and the Company (the “Agreement”) and contains all the terms and conditions relating to the services you agree to provide to the Company. Your appointment shall begin upon Nasdaq’s approval of Company’s listing.

…

EX-10.7·F-1/A·CIK 2049323·ACC 0001213900-26-094116·Filed Aug 27, 2026, 06:17 ET

EX-10.1

CrowdStrike Holdings, Inc.

CROWDSTRIKE HOLDINGS, INC.

OUTSIDE DIRECTOR COMPENSATION POLICY

CrowdStrike Holdings, Inc. (the “Company”) believes that the granting of equity and cash compensation to its members of the Board of Directors (the “Board,” and members of the Board, “Directors”) represents a powerful tool to attract, retain and reward Directors who are not employees of the Company (“Outside Directors”).  This Outside Director Compensation Policy (the “Policy”) is intended to formalize the Company’s policy regarding cash compensation and grants of equity to its Outside Directors.   Unless otherwise defined herein, capitalized terms used in this Policy will have the meaning given such term in the CrowdStrike Holdings, Inc. 2019 Equity Incentive Plan (the “Plan”).  Outside Directors will be solely responsible for any tax obligations they incur as a result of the equity and cash payments received under this Policy.

1.    CASH COMPENSATION

…

EX-10.1·10-Q·CIK 1535527·ACC 0001535527-26-000031·Filed Aug 26, 2026, 21:03 ET

EX-10.(A)

HP INC

Exhibit 10(a)

GRANT AGREEMENT

Director Name:         

Grant Date:        Grant Number:        Award Amount:        Award Type:            Restricted Stock UnitsPlan:            Fifth Amended and Restated HP Inc. 2004 Stock Incentive PlanVesting Schedule:        100% on the Grant Date

Restricted Stock Units

…

EX-10.(A)·10-Q·CIK 47217·ACC 0000047217-26-000051·Filed Aug 26, 2026, 19:04 ET

EX-10.2

Okta, Inc.

Okta, Inc.

Amended and Restated

Outside Director Compensation Policy

The purpose of this Outside Director Compensation Policy (this “Policy”) of Okta, Inc., a Delaware corporation (the “Company”), is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors, who are not employees or officers of the Company or its subsidiaries (“Outside Directors”), to serve on the Company’s Board of Directors (the “Board”). In furtherance of the purpose stated above, all Outside Directors shall be paid compensation for services provided to the Company as set forth below:

1.Cash Retainers

Effective as of March 19, 2026, the cash retainers for the Board, the Lead Independent Director, and the members and Chairpersons of any standing committee of the Board (as may be constituted from time to time) are revised as set forth below:

(a)Annual Board Membership Retainer. $35,000 for general availability and participation in meetings and conference calls of the Board.

…

EX-10.2·10-Q·CIK 1660134·ACC 0001660134-26-000069·Filed Aug 26, 2026, 18:05 ET

EX-10.1

Technology & Telecommunication Acquisition Corp

** **

AMENDMENT

TO THE

INVESTMENT MANAGEMENT TRUST AGREEMENT

This Amendment No. 7 (this “Amendment”), dated as of August 20, 2026, to the Investment Management Trust Agreement (as defined below) is made by and between Technology & Telecommunication Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). All terms used but not defined herein shall have the meanings assigned to them in the Trust Agreement.

WHEREAS, the Company and the Trustee entered into an Investment Management Trust Agreement dated as of January 14, 2022 (as amended on by Amendment No. 1, Amendment No.2, Amendment No.3, Amendment No. 4 Amendment No. 5, and Amendment No. 6 thereto, the “Trust Agreement”);

WHEREAS, Section 1(i) of the Trust Agreement sets forth the terms that govern the liquidation of the Trust Account under the circumstances described therein;

…

EX-10.1·8-K·CIK 1900679·ACC 0001493152-26-040261·Filed Aug 26, 2026, 17:05 ET

EXHIBIT 10.1

Autonomix Medical, Inc.

AUTONOMIX MEDICAL, INC.

August 24, 2026

Holder of Common Stock Purchase Warrants

Re:         Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

Autonomix Medical, Inc. (the “Company”) is pleased to offer to you the opportunity to exercise all of the Series D-1 warrants and Series D-2 warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued to you on July 15, 2026 (the “Existing Warrants”), as set forth on the signature page hereto and currently held by you (the “Holder”). The issuance of the shares of Common Stock underlying the Existing Warrants (the “Warrant Shares”) has been registered for resale pursuant to the registration statement on Form S-3 (File No. 333-297760) (the “Registration Statement”). The Registration Statement is currently effective and, upon exercise of the Existing Warrants pursuant to this letter agreement, will be effective for the resale of the Warrant Shares.** **Capitalized terms not otherwise defined herein shall have the meanings set forth in the New Warran

…

EX-10.1·8-K·CIK 1617867·ACC 0001437749-26-029024·Filed Aug 26, 2026, 17:02 ET